NEUARTIGE JNK-HEMMERMOLEKÜLE

Patent europeic · EP2993180 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2993180
Numer da la dumonda
EP15002211
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
21-06-2011
Publitgà
09-03-2016
Concedì
15-01-2020
Stritgà
25-01-2024
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 7/06 (2006.01)
C07K 14/47 (2006.01)
G01N 33/53 (2006.01)
Prioritad
WO PCT/EP2010/003729 21.06.2010
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-01-2024

    Stritgà, taxa betg pajada

    Published in Swissreg on 25.01.2024

  2. 10-02-2023

    Adressa midada

    Representative
    Riederer Hasler & Partner Patentanwälte AG, Kappelestrasse 15, 9492 Eschen, Liechtenstein → Swisspat Riederer Hasler Patentanwälte AG, Kappelestrasse 17, 9492 Eschen, Liechtenstein

    Published in Swissreg on 10.02.2023

  3. 01-07-2022

    Midada

    Published in Swissreg on 01.07.2022

  4. 04-03-2020

    Represchentant inscrit

    Representative
    Riederer Hasler & Partner Patentanwälte AG, Kappelestrasse 15, 9492 Eschen, Liechtenstein

    Published in Swissreg on 04.03.2020

  5. 15-01-2020

    Concedì

    Published in Swissreg on 15.01.2020

Partidas

Possessur

Xigen Inflammation Ltd.

Arch. Makariou III 195 Neocleous House, 3030 Limassol, CY

Represchentant

Swisspat Riederer Hasler Patentanwälte AG

Kappelestrasse 17, 9492 Eschen, LI

Inventur

Bonny, Christophe

1580 Avenches

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.